Phytonutrients Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Phytonutrients Market Trends and Insights

Surging Demand for Clean-Label Food and Beverage Fortification

The FDA's delisting of Red Dye No. 3 for food applications in 2024 prompted manufacturers to reformulate their products with natural alternatives. Food and beverage companies are increasingly incorporating natural color ingredients such as spirulina, beetroot red, and carotenoids to meet their branding, regulatory, and sensory requirements. Manufacturers have successfully offset the increased raw material costs through retail price premiums of 12-15% in 2025. The implementation of advanced extraction methods, particularly natural deep eutectic solvents, has achieved yield improvements exceeding 10% compared to traditional ethanol processes while supporting sustainability goals. The industry's transition toward clean-label ingredients has evolved significantly from a specialized market segment to become a primary consumer consideration, which continues to support sustained growth in the phytonutrients market. This shift reflects broader consumer preferences for natural ingredients and transparency in food products.

Heightened Consumer Awareness About Preventive Healthcare and Wellness

Growing awareness of preventive healthcare has increased consumer demand for phytonutrient-enriched products across all demographics. This shift reflects a broader transformation in health consciousness, where consumers actively seek natural compounds for their wellness routines. Research demonstrating phytonutrients' effects on inflammation and immune function has provided scientific validation that appeals to consumers seeking evidence-based health solutions. Multiple clinical studies have shown these compounds can help regulate various biological processes and support overall health maintenance. Advanced delivery systems like phytosomes improve the absorption of phytonutrients, meeting consumer requirements for effective products and supporting higher price points. These technological improvements have enabled manufacturers to develop more efficient formulations that maximize the therapeutic potential of plant-based compounds while ensuring better bioavailability.

Rising Prevalence of Chronic Diseases and Health Conditions

Government funding supports clinical trials of curcumin, sulforaphane, and other phytochemicals for cancer and cardiometabolic conditions, validating their therapeutic potential, according to the National Cancer Institute^{[2]Source: National Cancer Institute, “Natural Products for Cancer Prevention Research,” cancer.gov}. These trials are essential in establishing the efficacy and safety profiles of natural compounds in treating various diseases. Advanced nano-encapsulation technology enables controlled release of these compounds, with some combinations achieving LDL-cholesterol reduction comparable to pharmaceutical drugs. This technological advancement has significantly improved the bioavailability and effectiveness of natural compounds. The FDA's streamlined procedures for new dietary ingredients have reduced regulatory delays in product development, allowing companies to bring innovative products to market more efficiently. Following patent expirations of conventional statins and blood pressure medications, pharmaceutical companies are developing phytonutrient combinations to maintain revenue streams, indicating increased integration between nutritional and pharmaceutical approaches. This convergence represents a significant shift in the pharmaceutical industry's strategy toward incorporating natural compounds into their product portfolios.

Accelerating Demand for Immunity-Boosting Products

Post-pandemic immunity consciousness has created sustained demand for phytonutrient-based immune support products, extending beyond traditional seasonal patterns. The approval of new food ingredients, including microalgae oil and proanthocyanidins in China's health food regulations, demonstrates regulatory adaptation to consumer demand for diverse immunity-supporting compounds. The development of plant-derived exosome-like nanoparticles from fruits, vegetables, and herbs creates novel delivery mechanisms for immune-modulating phytonutrients, potentially revolutionizing functional food formulations. Clinical validation of phytonutrients' immunomodulatory effects in livestock applications provides translational insights for human health applications, particularly in stress-related immune suppression scenarios. The integration of traditional herbal knowledge with modern extraction technologies enables the commercialization of previously underutilized immunity-supporting plant compounds.

High Production Costs Associated with Phytonutrient Extraction and Processing

High production costs limit market growth by restricting access to price-sensitive consumers and reducing manufacturer profits. Traditional extraction methods require substantial energy and specialized equipment, particularly supercritical CO2 systems that demand significant capital investment from manufacturers. New extraction technologies, such as subcritical water processing and natural deep eutectic solvents, may reduce costs while maintaining product quality and environmental standards. Many phytonutrient categories struggle to achieve economies of scale due to scattered demand across applications and regions. While biotechnology methods like microbial fermentation and plant cell culture could lower long-term production costs and overcome agricultural limitations, they require substantial initial investment. Using agricultural by-products as phytonutrient sources helps reduce costs and improve sustainability.

Limited Availability of Raw Materials Due to Seasonal Dependencies and Agricultural Constraints

Supply chain vulnerabilities in raw material availability result in price volatility and sourcing uncertainties for manufacturers. Agricultural production patterns affected by climate change create yield variations that influence phytonutrient concentrations in source materials. The fresh produce supply chain faces additional challenges due to its perishable nature and reliance on cold chain infrastructure, affecting the consistency of raw materials needed for phytonutrient extraction. While companies implement diversification strategies through alternative plant sources and expanded geographic sourcing, these approaches require substantial investments in supplier development and quality control systems. Controlled environment agriculture and vertical farming technologies offer solutions to reduce seasonal dependencies and maintain consistent phytonutrient profiles, though cost-effectiveness remains a concern. The industry is exploring biotechnology solutions, including algae cultivation and synthetic biology methods, to address agricultural limitations and improve control over compound purity and concentration.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Type: Carotenoids Sustain Leadership While Polyphenols Accelerate

Carotenoids secured 38.12% of the phytonutrients market share in 2025, anchored in long-standing uses as colorants and antioxidants in foods and supplements. Their oxide-scavenging capacity and Provitamin A functions keep demand stable. Conversely, polyphenols deliver the highest 9.39% CAGR on mounting evidence of cardioprotective and neuroprotective benefits. Fermentation-based synthesis now sidesteps seasonal crop limits, improving batch-to-batch consistency and reducing solvent residues—all persuasive advantages for clean-label brand owners.

Strong clinical validation and cost-efficient production ensure carotenoids remain the revenue anchor of the phytonutrients market. However, innovations in galloyl-rich tannins, resveratrol analogs, and flavonol glycosides propel polyphenols toward double-digit gains, which could erode carotenoids’ dominance by the late decade. As precision-nutrition platforms link gene variants to oxidative-stress markers, polyphenol blends tailored to personal health profiles gain traction. These trends foreshadow a gradually rebalancing product mix within the wider phytonutrients market.

By Source: Fruits & Vegetables Dominate as Herbs and Trees Gain Momentum

Fruits and vegetables accounted for 53.21% of the phytonutrients market in 2025, supported by extensive agricultural production and consumer trust. Food processing byproducts such as tomato pomace, onion skins, and grape marc are increasingly used as raw materials, converting waste into valuable products while reducing environmental impact. The United States Department of Agriculture (USDA) reported vegetable production of 758 million cwt in 2023, ensuring a sufficient raw material supply.

Herbs and trees chart the fastest 8.33% CAGR, propelled by interest in adaptogenic compounds from ashwagandha, ginseng, and green tea catechins. Standardized extraction protocols ensure consistent potency, alleviating historical quality-control concerns. Cereals, pulses, and oilseeds offer cost-efficient scale yet must compete with food-use demand. Marine algae and synthetic-biology platforms represent longer-term alternatives that promise purity and environmental control but require further cost optimization before they reshape the phytonutrients market.

By Form: Powder Retains Majority Share as Liquids Win Convenience-Seekers

Powders dominated the phytonutrients market with a 65.12% share in 2025. This format offers significant advantages in stability, transportation efficiency, and compatibility with bakery, dairy, and meat analog applications. Processing methods like spray-drying, freeze-drying, and agglomeration help preserve active compounds while maintaining low water activity levels, ensuring product quality and shelf life. The incorporation of matrix-derived carriers, particularly pea-protein isolates, has substantially enhanced powder dispersibility characteristics and enabled the development of sugar-free formulations across various food and beverage applications.

Liquids, projected to grow 9.32% CAGR, appeal to ready-to-drink beverages, gummies, and drop-dose formats. Centrifugal-partition chromatography using renewable solvents boosts purity to pharmaceutical-grade standards without chlorinated residues. Capsules, tablets, and nanoemulsion shots serve premium niches where bioavailability claims command higher margins. Intelligent packaging that tracks oxidation in real time is under development and could extend shelf life, reinforcing consumer trust in both powder and liquid variants of the phytonutrients market.

By Application: Food and Beverages Lead While Pharmaceuticals Accelerate

The food and beverages segment dominated with a 50.92% market share in 2025, driven by manufacturers reformulating breakfast cereals, juices, and dairy products with natural pigments and antioxidants. Major food companies are increasingly incorporating these natural ingredients to meet consumer demand for clean-label products. The segment's growth is supported by favorable labeling regulations and the ability to make health claims, which enable manufacturers to highlight the nutritional benefits of natural ingredients. This regulatory environment, combined with rising consumer awareness of health benefits, continues to drive the adoption of natural pigments and antioxidants in food and beverage applications.

Pharmaceuticals, advancing at 10.32% CAGR, benefit from nano-carriers that resolve bioavailability hurdles of curcumin, resveratrol, and quercetin. FDA guidance on new dietary ingredient notifications in 2024 clarifies regulatory routes, accelerating commercialization. Dietary supplements remain an entrenched mid-market channel but now face competition from functional foods that blend convenience and health benefits. In animal nutrition, complex phytonutrient blends improve gut health and feed conversion, offering farmers antibiotic-free performance solutions—an adjacency expected to underpin incremental growth for the wider phytonutrients market.

Geography Analysis

North America held 41.22% of the phytonutrients market in 2025, leveraging robust regulatory clarity, investment in research and development, and consumer readiness to pay premium prices. Recent FDA approvals of butterfly pea flower and Galdieria-derived blue pigment boost the supply of natural colorants, further reinforcing market confidence. The region’s produce output, including 758 million cwt of vegetables in 2023, guarantees steady raw-material flows. E-commerce and personalized-nutrition subscription models accelerate direct-to-consumer adoption of superfood blends and targeted gummies.

Asia-Pacific is the fastest-growing region at an 8.52% CAGR, fueled by expanding middle-class populations, progressive regulations, and traditional-medicine heritage. China’s approval of new health-food ingredients such as microalgae oil and proanthocyanidins enriches the permissible ingredient list and widens product innovation latitude cfda.com. Indian Ayurveda and Japanese Foods with Function Claims further mainstream phytonutrient usage, while local contract-manufacturing ecosystems reduce production costs, enhancing export competitiveness.

Europe posts steady growth underpinned by stringent quality and sustainability standards. Adoption of green extraction technologies and life-cycle-assessment reporting supports premium brand positioning, though fragmented regulatory alignment across EU members adds time and cost. South America and the Middle East and Africa remain nascent but promising; agricultural abundance in Brazil and emerging nutraceutical demand in the Gulf Cooperation Council create fertile terrain for the future expansion of the phytonutrients market.

Regulatory Landscape

Globally, phytonutrients are regulated through the frameworks that apply to their specific use case (food additive, color additive, dietary ingredient, or novel food), rather than as a standalone legal category. That approach increases compliance complexity for multi-region formulations. In the United States, FDA oversight depends on pre-market authorization routes, including food additive regulations and GRAS determinations under 21 CFR Part 170, while color additives require explicit approval even when the source is plant-derived.

In Europe, concentrated plant extracts are often subject to the Novel Food Regulation (EU) 2015/2283, with EFSA conducting safety assessments before the European Commission updates the Union list under Implementing Regulation (EU) 2017/2470. Commission Implementing Regulation (EU) 2025/1509 (adopted July 2025) amended specifications for the authorized novel food phytosterols/phytostanols for Advanced Organic Materials SA, highlighting how specification updates and authorization status can affect supplier eligibility and product positioning.

Value Chain Analysis

The phytonutrients value chain begins with agricultural and botanical raw materials (fruits and vegetables, herbs and trees, and increasingly byproducts such as pomace and marc). This is followed by preprocessing (cleaning, drying, milling), extraction and purification (solvent-based, supercritical CO2, and fermentation/bioprocess routes), and stabilization into commercial forms, with powders leading and liquids and other delivery systems gaining share. Ingredient suppliers and compounders then sell to downstream users across food and beverages, dietary supplements, pharmaceuticals, cosmetics and personal care, and animal nutrition, using B2B direct sales, contract manufacturing ecosystems, and e-commerce-enabled finished-product brands.

Two operational shifts are increasingly apparent across the chain: tighter upstream control to improve traceability and supply security, and faster discovery-to-formulation cycles supported by data and bioinformatics. Nexira acquired Moroccan carob specialist Keragum in July 2026 to strengthen sourcing control and commissioning of regional processing capacity, while Evra Ingredients partnered with Brightseed in March 2026 to apply the Forager AI platform to identify and validate new plant bioactives for commercialization. Scale-up of extraction remains a bottleneck across production routes (capex, energy intensity, and batch consistency), which keeps purification and stabilization steps as key cost and quality-control inflection points.

Market Opportunities and Future Outlook

Opportunities are emerging where regulatory authorization and scientific substantiation translate into clearer commercialization pathways for novel plant extracts and more differentiated functional positioning. In the EU, Commission Implementing Regulation (EU) 2026/1306 (June 2026) authorized a rhamnogalacturonan-I enriched carrot extract as a novel food, providing a concrete precedent for suppliers pursuing high-purity, concentrated plant fractions beyond traditional preparations. In parallel, the updated US labeling environment, including FDA action redefining the term "healthy" in February 2025, supports reformulation programs that emphasize nutrient-dense fortification approaches where phytonutrient-containing ingredients can fit within compliant claims architectures.

Innovation whitespace is also expanding along three connected themes: accelerated discovery of underutilized bioactives, improved bioavailability and sensory performance, and more targeted personalization. Brightseed launched an AI-driven Forager platform in March 2026 that analyzes over 11 million natural compounds, reinforcing a shift toward computational screening to reduce R&D fragmentation and shorten time from botanical identification to ingredient development. Academic work in July 2026 also highlighted gut microbiome biotransformation of phytonutrients, supporting product concepts that connect plant compounds with microbiome-enabled functionality. Formulation roadmaps continue to emphasize encapsulation and related technologies to stabilize sensitive polyphenols and carotenoids across beverages, gummies, and pharma-adjacent formats.